San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium SABCS is an international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.

ICYMI: —Virginia Kaklamani talked with Hope Rugo about the field of endocrine therapy, including data from the Phase II...
01/21/2026

ICYMI: —Virginia Kaklamani talked with Hope Rugo about the field of endocrine therapy, including data from the Phase III evERA Breast Cancer Study and from the Phase II ELEVATE Study.
https://brnw.ch/21wZh2f

ICYMI: —At , Rahul Gosain of the Oncology Brothers talked with Mafalda Oliveira about next generation endocrine therap...
01/19/2026

ICYMI: —
At , Rahul Gosain of the Oncology Brothers talked with Mafalda Oliveira about next generation endocrine therapies—including oral SERDs and PROTAC estrogen receptor degraders—and whether they are working better for patients.
https://brnw.ch/21wZdaL

ICYMI: —Rohit Gosain of the Oncology Brothers talked with Kristy Brown at about the biological link between obesity a...
01/16/2026

ICYMI: —
Rohit Gosain of the Oncology Brothers talked with Kristy Brown at about the biological link between obesity and the risk of breast cancer.
https://brnw.ch/21wZ9tB

ICYMI: —Saba Shaikh, MD, talked with Thorsten Kühn about the AXSANA/EUBREAST 3 study, which showed that, in patients wh...
01/13/2026

ICYMI: —
Saba Shaikh, MD, talked with Thorsten Kühn about the AXSANA/EUBREAST 3 study, which showed that, in patients who convert from clinically node-positive to node-negative breast cancer, less invasive surgical staging procedures are associated with a low axillary recurrence rate.
https://brnw.ch/21wZ3hs

ICYMI: —Mylin Torres talked with Guido Hildebrandt about the secondary results of the INSEMA trial, which evaluated app...
01/08/2026

ICYMI: —
Mylin Torres talked with Guido Hildebrandt about the secondary results of the INSEMA trial, which evaluated applied radiotherapy among patients undergoing breast-conserving surgery with or without axillary sentinel lymph node biopsy.
https://brnw.ch/21wYVUn

ICYMI: —Rahul Gosain of the Oncology Brothers talked with Marleen Kok about how lobular carcinoma—which comprises 10-15...
01/05/2026

ICYMI: —
Rahul Gosain of the Oncology Brothers talked with Marleen Kok about how lobular carcinoma—which comprises 10-15% of all invasive breast cancers—differs from ductal carcinoma.
https://brnw.ch/21wYQBJ

ICYMI: — Program Director Kate Lathrop talked with Shom Goel about CDK4/6 inhibitors and emerging options to advance t...
12/31/2025

ICYMI: —
Program Director Kate Lathrop talked with Shom Goel about CDK4/6 inhibitors and emerging options to advance treatment for HR+HER- metastatic breast cancer.
https://brnw.ch/21wYKEX

New Best of SABCS® 2025 Video Highlight:Get the high-impact results from SABCS from Dr. Hope Rugo as she drills down int...
12/22/2025

New Best of SABCS® 2025 Video Highlight:
Get the high-impact results from SABCS from Dr. Hope Rugo as she drills down into biomarker subgroup analysis of the evERA phase III trial for giredestrant + everolimus and updated EMBER-3 efficacy of imlunestrant in advanced breast cancer, alongside the WISDOM 1.0 results on risk-based screening. Watch now:
https//www.bestofsabcs.com/videohighlights

New Best of SABCS® 2025 Video Highlight:Ruth O'Regan, MD of the University of Rochester summarizes the 2025 FDA approval...
12/19/2025

New Best of SABCS® 2025 Video Highlight:
Ruth O'Regan, MD of the University of Rochester summarizes the 2025 FDA approvals for HR+ metastatic breast cancer, including datopotamab deruxtecan, trastuzumab deruxtecan, and imlunestrant. Watch now:
https://brnw.ch/21wYv55

: Virginia Kaklamani talked with Hope Rugo about the field of endocrine therapy, including data from the Phase III evER...
12/18/2025

: Virginia Kaklamani talked with Hope Rugo about the field of endocrine therapy, including data from the Phase III evERA Breast Cancer Study and from the Phase II ELEVATE Study.
https://brnw.ch/21wYtoV

New Best of SABCS® 2025 Video Highlight:Catch up on the year in MBC with Dr. Janice Tsang, Deputy Chair for W4O and ESMO...
12/18/2025

New Best of SABCS® 2025 Video Highlight:
Catch up on the year in MBC with Dr. Janice Tsang, Deputy Chair for W4O and ESMO, as she offers the highlights on TNBC (ASCENT-04, ASCENT-03, TROPION Breast-02), HER2+ (DESTINY Breast-09, HER2CLIMB-05) and HR+/HER2- metastatic breast cancer (VERITAC-2, VIKTORIA-1, eVERA, EMBER-3, SERENA-6, TROPION Breast-01). Watch now:
https://brnw.ch/21wYthM

New Best of SABCS® 2025 Video Highlight:Critical updates for EBC—William Gradishar synthesizes the year's most impactful...
12/17/2025

New Best of SABCS® 2025 Video Highlight:
Critical updates for EBC—William Gradishar synthesizes the year's most impactful clinical findings at and highlights neoadjuvant trials like TBCRC056 and OlympiaN that explore the role of PARP inhibitors and immunotherapy in early BRCA-mutated breast cancer. Watch now:
https://brnw.ch/21wYrDn

Address

7979 Wurzbach Road, MC 8224
San Antonio, TX
78229

Telephone

+12104501550

Website

Alerts

Be the first to know and let us send you an email when San Antonio Breast Cancer Symposium posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram